Camurus Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Lund, Sweden
Total Funding:N/A
Industry:Pharma
Founded:1991
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Camurus's estimated annual revenue is currently $25.5M per year.
  • Camurus's estimated revenue per employee is $201,000

Employee Data

  • Camurus has 127 Employees.
  • Camurus grew their employee count by 38% last year.
  • Camurus currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$10.7M5351%N/A-N/A
#2
$13.5M6791%N/A-N/A
#3
$10.9M5426%N/A-N/A
#4
$15.5M7713%N/A-N/A
#5
$25.5M12738%N/A-N/A
#6
$20.7M10312%N/A-N/A
#7
$33.6M167169%N/A-N/A
#8
$38.6M19248%N/A-N/A
Missing a competitor? Contribute!?
Submit

Camurus is a Swedish research-based pharmaceutical company committed to developing and commercialising innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the proprietary FluidCrystal® drug delivery technologies and an extensive R&D expertise. Camurus clinical pipeline includes products for treatment of cancer, endocrine diseases, pain and addiction, developed in-house and in collaboration with international pharmaceutical companies. The company's shares are listed on Nasdaq Stockholm under the ticker CAMX.

keywords:N/A

127

Number of Employees

$25.5M

Revenue (est)

1

Current Jobs

38%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Camurus News

09/03/2019 - Camurus: Australian Minister for Health Announced PBS ...

LUND, Sweden, Aug. 26, 2019 /PRNewswire/ -- The Australian Federal Health Minister Greg Hunt announced on Sunday that Camurus' ...

09/08/2019 - Camurus AB (publ)'s (STO:CAMX) Shift From Loss To Profit

Camurus AB (publ)'s (STO:CAMX): Camurus AB (publ), a research-based pharmaceutical company, develops and commercializes ...

09/03/2019 - Camurus AB (publ) (OM:CAMX) Year Over Year With Profit Growth of 0.37383: Is it Time to Buy?

Camurus AB (publ) (OM:CAMX) has posted year over year net profit growth of 0.37383. The net profit number is the nuts and bolts of a firm's ...